Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9714296
SERIAL NO

14727135

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies and their fragments that are immunoreactive to the mammalian, and more particularly, the human B7-H3 receptor and to uses thereof, particularly in the treatment of cancer and inflammation. The invention thus particularly concerns humanized B7-H3-reactive antibodies and their immunoreactive fragments that are capable of mediating, and more preferably enhancing the activation of the immune system against cancer cells that are associated with a variety of human cancers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MACROGENICS INC9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Francine Zhifen San Francisco, US 10 93
Huang, Ling Bethesda, US 138 3413
Johnson, Leslie S Darnestown, US 170 4245
Loo, Deryk T Belmont, US 24 261
Moore, Paul A North Bethesda, US 236 2276

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 25, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 25, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00